Tali Digital Ltd · ASX:TD1
Tali Digital — Shareholder Meeting (November 2018)
27 slides from Tali Digital's shareholder meeting presentation, Nov 29, 2018
Slide 1: Chair's Address and Managing Director's Presentation
ASX Announcement Date:29 November 2018 NOVITA HEALTHCARE LIMITED CHAIR’S ADDRESS AND MANAGING DIRECTOR’S PRESENTATION Novita Healthcare Limited (ASX:NHL or the Company) announces that at the 2018 Annual General Meeting held today, Thursday 29 November 2018, the following Chair’s Address to sharehold
Slide 2: About Novita Healthcare
ASX Announcement Date:29 November 2018 ABOUT NOVITA HEALTHCARE Novita Healthcare is an emerging health sector technology company targeting ATTENTION in children through its breakthrough technology TALI. TALI Train uses proprietary algorithms inside a game-based learning application to improve core a
Slide 3: Annual General Meeting 2018
ŶŶƵĂů'ĞŶĞƌĂůDĞĞƚŝŶŐͮϮϬϭϴ ^y͗E,>;ǁǁǁ͘ŶŽǀŝƚĂŚĞĂůƚŚĐĂƌĞ͘ĐŽŵ͘ĂƵͿ
Slide 4: Disclaimer
',6&/$,0(5 ^ŽŵĞŽĨƚŚĞƐƚĂƚĞŵĞŶƚƐŝŶƚŚŝƐƉƌĞƐĞŶƚĂƚŝŽŶĐŽŶƐƚŝƚƵƚĞ͞ĨŽƌǁĂƌĚͲůŽŽŬŝŶŐƐƚĂƚĞŵĞŶƚƐ͟ƚŚĂƚ ĚŽŶŽƚĚŝƌĞĐƚůLJŽƌĞdžĐůƵƐŝǀĞůLJƌĞůĂƚĞƚŽŚŝƐƚŽƌŝĐĂůĨĂĐƚƐ͘ dŚĞƐĞĨŽƌǁĂƌĚͲůŽŽŬŝŶŐƐƚĂƚĞŵĞŶƚƐƌĞĨůĞĐƚEŽǀŝƚĂ,ĞĂůƚŚĐĂƌĞ>ŝŵŝƚĞĚ͛ƐĐƵƌƌĞŶƚŝŶƚĞŶƚŝŽŶƐ͕ ƉůĂŶƐ͕ĞdžƉĞĐƚĂƚŝŽŶƐ͕ĂƐƐƵŵƉƚŝŽŶƐĂŶĚďĞůŝĞĨƐĂďŽƵƚĨƵƚƵƌĞĞǀĞŶƚƐĂŶĚĂƌĞƐƵďũĞĐƚƚŽƌŝƐŬƐ͕
Slide 5: Global Business Opportunity
129,7$,19(670(17+,*+/,*+76 *OREDO%XVLQHVV2SSRUWXQLW\ WƌŽĚƵĐƚďƵŝůƚĂŶĚĐůĞĂƌĞĚƚŽŵĂƌŬĞƚͲ d>/dƌĂŝŶ;Zd'ůĂƐƐϭ͕&ůĂƐƐϮͿŝƐĂ ďƌĞĂŬƚŚƌŽƵŐŚŐĂŵĞͲďĂƐĞĚƚƌĂŝŶŝŶŐƚĞĐŚŶŽůŽŐLJĨŽĐƵƐĞĚŽŶƚƌĞĂƚŝŶŐĐŚŝůĚŚŽŽĚĂƚƚĞŶƚŝŽŶ ĐĐĞƐƐƚŽŝŶƐƵƌĂŶĐĞƐĐŚĞŵĞ;ƐͿͲ ĂƉƉƌŽǀĂůĂƐĂZĞŐŝƐƚĞƌĞĚWƌŽǀŝĚĞƌŝŶƚŚĞEĂƚŝŽŶĂůŝƐĂďŝůŝƚLJ /ŶƐƵƌĂŶĐĞ^ĐŚĞŵĞ;E/^Ϳ 'ůŽď
Slide 6: Company profile
&25325$7(29(59,(: $6;1+/ &RPSDQ\SURILOH )LQDQFLDOLQIRUPDWLRQ 6KDUHSULFH 1RY $ EŽǀŝƚĂ ŝƐĂĚŝŐŝƚĂůĚĞǀŝĐĞĚĞǀĞůŽƉŵĞŶƚĂŶĚ 1XPEHURIVKDUHV P ĐŽŵŵĞƌĐŝĂůŝƐĂƚŝŽŶďƵƐŝŶĞƐƐ 0DUNHWFDSLWDOLVDWLRQ $P /ŶŝƚŝĂůƉƌŽĚƵĐƚůĂƵŶĐŚĞĚďLJǁŚŽůůLJŽǁŶĞĚ &DVK 6HSW $P ƐƵďƐŝĚŝĂƌLJ;d>/,>d,ͿŝŶ:ƵůLJϮϬϭϴ 'HEW 6HSW 1RGHEW (QWHUSULVHYDOXH $
Slide 7: What We Do and Why We Do It
:+$7 :('2$1':+< :('2,7 EŽǀŝƚĂŝƐďƵŝůĚŝŶŐĂŶĚĐŽŵŵĞƌĐŝĂůŝƐŝŶŐĚŝŐŝƚĂůƚĞĐŚŶŽůŽŐŝĞƐ KƵƌƐŽůƵƚŝŽŶƐĚĞůŝǀĞƌƉŽƐŝƚŝǀĞŚĞĂůƚŚĂŶĚǁĞůůďĞŝŶŐŽƵƚĐŽŵĞƐ DŝƐƐŝŽŶ͗tĞƐƚƌŝǀĞƚŽĚĞůŝǀĞƌŵĂƌŬĞƚůĞĂĚŝŶŐ͕ ŽƵƚĐŽŵĞĨŽĐƵƐĞĚĚŝŐŝƚĂůŚĞĂůƚŚĂŶĚǁĞůůďĞŝŶŐ ƚĞĐŚŶŽůŽŐLJ sĂůƵĞƐ͗&ŽĐƵƐŽŶŝŶŶŽǀĂƚŝŽŶ͕ĐŽůůĂďŽƌĂƚŝŽŶ͕ ŵĂƌŬĞƚƐĐĂůĞ͕ĞŵƉĂƚŚLJ͕ĐŽŵŵƵŶŝƚLJďĞŶĞĨ
Slide 8: The Company
7+(&203$1< 2XUZKROO\RZQHGVXEVLGLDU\7$/,+HDOWK d>/,ĞĂůƚŚ͗ĐŽŵƉĂŶLJǁĂƐĨŽƌŵĞĚƚŽ ĐŽŵŵĞƌĐŝĂůŝƐĞŝŶƚĞůůĞĐƚƵĂůƉƌŽƉĞƌƚLJĨƌŽŵĂŶŽŶŐŽŝŶŐϮϬн LJĞĂƌDŽŶĂƐŚhŶŝǀĞƌƐŝƚLJŶĞƵƌŽƐĐŝĞŶĐĞƌĞƐĞĂƌĐŚƉƌŽũĞĐƚ d>/dƌĂŝŶ͗ ƉĂƚĞŶƚĞĚĚŝŐŝƚĂůƉůĂƚĨŽƌŵƚĞĐŚŶŽůŽŐLJ ƉƌŽǀŝĚŝŶŐĚŝƌĞĐƚƚŚĞƌĂƉĞƵƚŝĐĂĐƚŝǀŝƚLJ͕ ĚĞůŝǀĞƌĞĚŶŽƚƚŚƌŽƵŐŚĂƉŝůů͕ďƵƚƚŚƌŽƵŐŚĂŐĂŵĞďĂƐ
Slide 9: The Company – Your Board and Team
7+(&203$1<± <RXU%RDUGDQGWHDP 6XH0DF/HPDQ *OHQQ6PLWK -HIIHUVRQ+DUFRXUW 0DUN6LPDUL 6XHKDVPRUHWKDQ 2YHUWZHQW\\HDUV )RXQGHURI*UH\ 6LJQLILFDQWH[SHULHQFHRQ \HDUV¶H[SHULHQFHDVD H[SHULHQFHLQOHDGLQJ ,QQRYDWLRQVLJQLILFDQW ERDUGVLQSULYDWHO\KHOG SKDUPDFHXWLFDO FXVWRPHUFHQWULF SURGXFWGHYHORSPHQWDQG DQG$6
Slide 10: FY 2017/2018 – Building the Foundation, Drive to Sales Growth
)<± %XLOGLQJWKH)RXQGDWLRQ'ULYHWR 6DOHV*URZWK&RQWLQXHG&RPPLWPHQWWR,QQRYDWLRQ -XO\ 2FW $SU -XO\ 2FW &DSLWDO 'HYHORSPHQW &RPPHUFLDOLVDWLRQ 2SWLPLVDWLRQ 6DOHV *URZWK ŽƌƉŽƌĂƚĞƐƚƌƵĐƚƵƌĞ ZĞĐƌƵŝƚŵĞŶƚŽĨK WŝůŽƚ;ƉƌĞͲŵĂƌŬĞƚŝŶŐͿ ZĞůĞĂƐĞŽĨd>/ ĨŽĐƵƐŽŶd>/dƌĂŝŶ ŽƉƚŝŵŝƐĞĚ ƚŽĚƌŝǀĞƉƌŽĚƵĐƚ ƌĞůĞĂƐĞŽĨd>/dƌĂŝŶ dƌĂŝŶŝŶƚŽƚŚĞ
Slide 11: Where Are We Today? Novita Driving Our TALI Products to Market
:+(5($5(:(72'$<"129,7$'5,9,1*2857$/, 352'8&76720$5.(7 /ŶŵĂƌŬĞƚ;d>/dƌĂŝŶͿǁŝƚŚd>/ĞƚĞĐƚŽŶƚƌĂĐŬĨŽƌϮϬϭϵůĂƵŶĐŚ ZĞĐĞŝƉƚƐ&ƌŽŵƵƐƚŽŵĞƌƐ ΕϮϬϬƉƌŽǀŝĚĞƌƐ;ŝŶĐůƵĚŝŶŐŵƵůƚŝƉůĞƐĐŚŽŽůƐͿ ΨϳϬ͕ϬϬϬ͘ϬϬ ĚĞůŝǀĞƌŝŶŐd>/dƌĂŝŶ d>/ >ĂƵŶĐŚ ΨϲϬ͕ϬϬϬ͘ϬϬ /ŶƵƐƚƌĂůŝĂŶŵĂƌŬĞƚǁŝƚŚ ŝŶŝƚŝĂůĐƵƐƚŽŵĞƌƐĂůƐŽ ΨϱϬ͕ϬϬϬ͘ϬϬ ŝŶ͗ ^ŝŶŐĂƉŽƌĞ ΨϰϬ͕ϬϬϬ͘
Slide 12: Where Are We Heading In and Beyond?
:+(5($5(:(+($',1*,1$1'%(<21'" 'ůŽďĂůĨƌŽŵĚĂLJŽŶĞŵĞĂŶƐĚĞůŝǀĞƌŝŶŐŽƵƌĂƉƉƐƚŽĂŐůŽďĂůĂƵĚŝĞŶĐĞǀŝĂŵƵůƚŝƉůĞĐŚĂŶŶĞůƐ ʹ Ğ͘Ő͘ĚŝƌĞĐƚƚŽƉĂƌĞŶƚǀŝĂĂƉƉƐƚŽƌĞ͕ƐĐŚŽŽůƐ͕ŚĞĂůƚŚĐĂƌĞƉƌŽĨĞƐƐŝŽŶĂůƐ͕ĐŚĂŶŶĞůƉĂƌƚŶĞƌƐ ŽŶƚŝŶƵĞƚŽŐƌŽǁŝŶŵĂƌŬĞƚƐ͗ ƵƐƚƌĂůŝĂ ,ŽŶŐ<ŽŶŐ ^ŝŶŐĂƉŽƌĞ džƉĂŶƐŝŽŶŝŶƚŽ͗ EŽƌƚŚŵĞƌŝĐĂ h<ĂŶĚƵƌŽƉĞ h^ƚƚĞŶƚŝŽŶ
Slide 13: Why? Science and Technology Combining to Deliver Optimised Medicine
%87:+<" 6FLHQFHDQG7HFKQRORJ\ &RPELQLQJWR'HOLYHU2SWLPLVHG0HGLFLQH ŝŐŝƚĂůƚŚĞƌĂƉĞƵƚŝĐƐĂƌĞĂŶĞǁĐĂƚĞŐŽƌLJŽĨĂƉƉƐƚŚĂƚŚĞůƉƚƌĞĂƚŵĞĚŝĐĂůĐŽŶĚŝƚŝŽŶƐƚŽŝŵƉƌŽǀĞ ůŽŶŐͲƚĞƌŵŚĞĂůƚŚŽƵƚĐŽŵĞƐ ŝŐŝƚĂůƐĐƌĞĞŶŝŶŐĂŶĚƚŚĞƌĂƉĞƵƚŝĐƐĂƌĞƚŽŽůƐ͕ƐƵĐŚĂƐŵŽďŝůĞĂƉƉƐĂŶĚƉůĂƚĨŽƌŵƐ͕ǁŚŽƐĞ ŝŶƚĞƌǀĞŶƚŝŽŶƐŵĂLJĐŽŵƉůĞŵĞŶƚŽƌƌĞƉůĂĐĞƚƌĂĚŝƚŝŽŶĂůŵĞĚŝĐŝŶĞ
Slide 14: Attention – A Global Issue
$77(17,21± $*OREDO,VVXH ƚƚĞŶƚŝŽŶƉƌŽďůĞŵƐĂƌĞƚŚĞŵŽƐƚĐŽŵŵŽŶůLJƌĞƉŽƌƚĞĚĐŚŝůĚŚŽŽĚŝƐƐƵĞ >ĂĐŬŽĨĂƚƚĞŶƚŝŽŶŚĂƐĂĚĞƚƌŝŵĞŶƚĂůŝŵƉĂĐƚŽŶĞĚƵĐĂƚŝŽŶ͕ƐŽĐŝĂůŝŶĐůƵƐŝŽŶƐĂŶĚŐĞŶĞƌĂů ǁĞůůďĞŝŶŐ ϰϬϬ͕ϬϬϬĐŚŝůĚƌĞŶŝŶƵƐƚƌĂůŝĂŚĂǀĞƐĞǀĞƌĞĂƚƚĞŶƚŝŽŶĚŝĨĨŝĐƵůƚŝĞƐ 'ůŽďĂůůLJϭϯϲŵŝůůŝŽŶĐŚŝůĚƌĞŶŚĂǀĞƐĞǀĞƌĞĂƚƚĞŶƚŝŽŶĚŝĨĨŝĐƵůƚŝĞƐ ϰϬйŽĨĐŚŝůĚƌ
Slide 15: Our Current and Future Pathways
285&855(17$1')8785(3$7+:$<6 3URGXFW1RZDQGD3LSHOLQHWR*URZWK ŝŐŝƚĂůƐŽĨƚǁĂƌĞĂŶĚĚĞǀŝĐĞƐƚƌĂƚĞŐLJʹ &ŽĐƵƐŽŶĚŽŵĞƐƚŝĐŐƌŽǁƚŚďĞĨŽƌĞĞdžƉĂŶĚŝŶŐŝŶƚŽŐůŽďĂůŵĂƌŬĞƚƐ͕ ĂůůŽǁŝŶŐƵƐƚŽůĞǀĞƌĂŐĞŽĨĨƐŝŵŝůĂƌŵĂƌŬĞƚŝŶŐĐŚĂŶŶĞůƐĂŶĚŝŶƐƵƌĂŶĐĞƐĐŚĞŵĞƐĨŽƌŽƵƌĐƵƌƌĞŶƚĂŶĚĨƵƚƵƌĞ ƚĞĐŚŶŽůŽŐŝĞƐ d>/,>d, /ŶŵĂƌŬĞƚ;ƵƐƚƌĂůŝĂͿʹ Zd' ĚĚĂĚĚŝƚŝŽŶĂůƐĞƌǀŝĐĞ
Slide 16: TALI Train – A Digital, Adaptive Program with Proven Results
7$/,7UDLQ± $'LJLWDO$GDSWLYH 3URJUDPZLWK3URYHQ5HVXOWV
Slide 17: Science Meets Design to Deliver Clinical Outcomes
6&,(1&(0((76'(6,*1 7R'HOLYHU&OLQLFDO2XWFRPHV d>/dƌĂŝŶʹ ŶĞƵƌŽƐĐŝĞŶƚŝƐƚƐĐŽŵďŝŶŝŶŐǁŝƚŚŐĂŵĞĚĞƐŝŐŶĞƌƐƚŽĚĞůŝǀĞƌĂǁŽƌůĚůĞĂĚŝŶŐ͕ŐĂŵĞďĂƐĞĚĚŝŐŝƚĂů ƚƌĞĂƚŵĞŶƚ͘dŚĞƉƌŽŐƌĂŵŝƐ͖ ǀŝĚĞŶĐĞďĂƐĞĚʹ ƚŚŝƐŝƐŶŽƚũƵƐƚĂŶŽƚŚĞƌďƌĂŝŶƚƌĂŝŶŝŶŐĂƉƉ͘dŚŝƐŝƐĂƉƌŽŐƌĂŵĚĞǀĞůŽƉĞĚĂŶĚĞǀĂůƵĂƚĞĚďLJ ĐŽŐŶŝƚŝǀĞŶĞƵƌŽƐĐŝĞŶƚŝƐƚƐǁŚŽƐƉĞĐŝĂůŝƐĞŝŶĐŚŝůĚŚŽŽĚĚ
Slide 18: TALI Train Exercises
$*$0(%$6('352*5$07+$7,6)81 $1' 5(:$5',1* :,7+$/*25,7+067+$7'(/,9(5 $&/,1,&$//<3529(175($70(17 d>/dƌĂŝŶdžĞƌĐŝƐĞƐ 5HVHDUFKSXEOLVKHGLQ-RXUQDORI&KLOG3V\FKRORJ\DQG3V\FKLDWU\DQG$PHULFDQ-RXUQDORI,QWHOOHFWXDODQG'HYHORSPHQW'LVDELOLWLHV
Slide 19: The Importance of Early Intervention
7+(,03257$1&(2)($5/<,17(59(17,21 KƵƌŬĞLJĂƵĚŝĞŶĐĞƐƵŶĚĞƌƐƚĂŶĚƚŚĞůĂƌŐĞƵŶŵĞƚŵĂƌŬĞƚŽƉƉŽƌƚƵŶŝƚLJĨŽƌƚŚĞŶŽŶͲƉŚĂƌŵĂĐĞƵƚŝĐĂů ƚƌĞĂƚŵĞŶƚŽĨĐŚŝůĚŚŽŽĚĂƚƚĞŶƚŝŽŶĚŝƐŽƌĚĞƌƐʹ EKs/dŝƐƉŽƐŝƚŝŽŶĞĚĂƚƚŚĞĨŽƌĞĨƌŽŶƚŽĨƚŚŝƐ ŽƉƉŽƌƚƵŶŝƚLJ >/E//E^ ^,KK>^ WZEd^ /ƚŝƐĐůŝŶŝĐĂůůLJƉƌŽǀĞŶĂŶĚǁĞůůͲŬŶŽǁŶ ĂƌůLJŝŶƚĞƌǀĞŶƚŝŽŶǁŝůůƉƌĞƐĞŶƚ ĂŵŽŶŐƐƚƚŚĞĐůŝŶ
Slide 20: Who Is It For?
:+2,67$/,)25" ůůĐŚŝůĚƌĞŶƌĞƋƵŝƌĞƐƵƉƉŽƌƚŝŶƐƚƌĞŶŐƚŚĞŶŝŶŐĂƚƚĞŶƚŝŽŶ WƌŝŵĂƌŝůLJĨŽƌĐŚŝůĚƌĞŶϯͲϴLJĞĂƌƐŽĨĂŐĞ ;ĚĞǀĞůŽƉŵĞŶƚĂůĂŐĞͿ ĂŶĂƐƐŝƐƚ>>ĐŚŝůĚƌĞŶĚŝƐƉůĂLJŝŶŐůĂĐŬŽĨ ĂƚƚĞŶƚŝŽŶ dŚŽƐĞǁŝƚŚĂĐůŝŶŝĐĂůĚŝĂŐŶŽƐŝƐƐƵĐŚĂƐ ƵƚŝƐŵ^ƉĞĐƚƌƵŵŝƐŽƌĚĞƌ;^Ϳ WƌŽǀŝĚĞƐŽƵƚĐŽŵĞƐĨŽƌƚŚŽƐĞĚŝƐƉůĂLJŝŶŐ ƐLJŵƉƚŽŵƐƌĞůĂƚĞĚƚŽƚƚĞŶƚŝŽŶĞĨŝĐŝƚ ,LJƉĞƌĂ
Slide 21: TALI Train Provides Healthcare Professionals, Teachers and Parents with a New Option
)257+26(:,7+$&/,1,&$/',$*126,6 7$/,7UDLQ3URYLGHV+HDOWKFDUH3URIHVVLRQDOV7HDFKHUVDQG 3DUHQWVZLWKD1HZ2SWLRQ³$1HZ7RROLQWKH7RRONLW´ WƐLJĐŚŽƐƚŝŵƵůĂŶƚŵĞĚŝĐĂƚŝŽŶŝƐƚŚĞŵŽƐƚĐŽŵŵŽŶƚƌĞĂƚŵĞŶƚĨŽƌĂƚƚĞŶƚŝŽŶĚŝĨĨŝĐƵůƚŝĞƐĂŶĚŚĂƐďĞĞŶ ƐŚŽǁŶƚŽďĞĞĨĨĞĐƚŝǀĞŝŶƚŚĞƐŚŽƌƚƚĞƌŵ͘,ŽǁĞǀĞƌ͖ ƚŚĞůŽŶŐƚĞƌŵŝŵƉĂĐƚƐĂƌĞƐƚŝůůďĞŝŶŐŝŶǀĞƐƚŝŐĂƚĞĚ
Slide 22: The Evidence
7+((9,'(1&(± 7$/,LV(IIHFWLYHIRU&KLOGUHQ ZLWK'HYHORSPHQW'LVRUGHUVDVZHOODV7\SLFDOO\ 'HYHORSLQJ&KLOGUHQ ZĞƐƵůƚƐŽĨĂƌŝŐŽƌŽƵƐĚŽƵďůĞͲďůŝŶĚƌĂŶĚŽŵŝƐĞĚĐŽŶƚƌŽůůĞĚĐůŝŶŝĐĂůƚƌŝĂů ŝŶǀĞƐƚŝŐĂƚŝŶŐƚŚĞĞĨĨĞĐƚŝǀĞŶĞƐƐŽĨd>/dƌĂŝŶŚĂǀĞƐŚŽǁŶƚŚĂƚĐŚŝůĚƌĞŶ ǁŚŽƵƐĞĚd>/dƌĂŝŶǀƐĂŶŽƚŚĞƌƚŽƵĐŚƐĐƌĞĞŶƉƌŽŐƌĂŵĨŽƌƚŚĞƐĂŵĞ ƉĞƌŝŽĚŽĨƚŝŵĞĂƌĞĂƐĨŽůů
Slide 23: How Do We Know It's Working?
+2:'2:(.12:,7,6:25.,1*" ϵϯйŽĨƵƐĞƌƐŚĂǀĞĚĞŵŽŶƐƚƌĂƚĞĚƉŽƐŝƚŝǀĞŝŵƉƌŽǀĞŵĞŶƚƐŝŶ͗ ĂͿ/ŶĂƚƚĞŶƚŝǀĞďĞŚĂǀŝŽƵƌĂŶĚďͿ,LJƉĞƌĂĐƚŝǀĞďĞŚĂǀŝŽƵƌ ǀĞƌĂŐĞƐĐŽƌĞĂŶĚŝŵƉƌŽǀĞŵĞŶƚΎ ĞĨŽƌĞdƌĂŝŶŝŶŐ ĨƚĞƌdƌĂŝŶŝŶŐ ŝĨĨĞƌĞŶĐĞďĞĨŽƌĞͲĂĨƚĞƌ dŽƚĂů^ĐŽƌĞ Ϯϳ ϵ Ͳϭϴ /ŶĂƚƚĞŶƚŝǀĞ ϭϰ ϰ ͲϭϬ ĞŚĂǀŝŽƵƌ ,LJƉĞƌĂĐƚŝǀĞ ϭϯ ϱ Ͳϴ ĞŚĂǀŝŽƵƌ ΎdŚĞůŽǁĞƌƚŚĞƐĐŽƌĞƚŚĞĨĞǁ
Slide 24: Not Just Attention Results But Happy Children
127-867$77(17,215(68/76 %87+$33<&+,/'5(1
Slide 25: And Very Happy Schools Referencing TALI Train
$1'9(5<+$33<6&+22/6 5()(5(1&,1*7$/,75$,1
Slide 26: Key Actions in 2019
.(<$&7,216,1± GHOLYHURQRXUSURPLVHRI SURGXFWLQWKHKDQGVRIFKLOGUHQ ŽŶƚŝŶƵĞƚŽƌĞĐƌƵŝƚƐĐŚŽŽůƐĂƐĐůŝĞŶƚƐŽĨd>/dƌĂŝŶďƵŝůĚŝŶŐ ƌĞĨĞƌĞŶĐĞĂďůĞĐůŝĞŶƚďĂƐĞŝŶƵƐƚƌĂůŝĂ͕^ŝŶŐĂƉŽƌĞ͕,ŽŶŐ<ŽŶŐ ƌŝǀĞƐĂůĞƐŐƌŽǁƚŚƚŚƌŽƵŐŚŝŶƚĞŐƌĂƚĞĚŵĂƌŬĞƚŝŶŐĂŶĚƐĂůĞƐ ƉƌŽŐƌĂŵƐ WƌĞͲŵĂƌŬĞƚŝŶŐĂĐƚŝǀŝƚŝĞƐŝŶEŽƌƚŚŵĞƌŝĐĂĂŶĚƵƌŽƉĞ;WĂƌƚŶĞƌƐͿ d>/ĞƚĞĐƚǁŝĚĞƐƉ
Slide 27: Investors Please Contact
/ŶǀĞƐƚŽƌƐƉůĞĂƐĞĐŽŶƚĂĐƚ͗'ůĞŶŶ^ŵŝƚŚ͕DĂŶĂŐŝŶŐŝƌĞĐƚŽƌ ŵĂŝů͗ŝŶĨŽΛŶŽǀŝƚĂŚĞĂůƚŚĐĂƌĞ͘ĐŽŵ͘ĂƵ